|
Q3 FY2026
As of Jun 30, 2026
|
Q2 FY2026
As of Mar 31, 2026
|
Q1 FY2026
As of Dec 31, 2025
|
Q4 FY2025
As of Sep 30, 2025
|
Q3 FY2025
As of Jun 30, 2025
|
Q2 FY2025
As of Mar 31, 2025
|
Q1 FY2025
As of Dec 31, 2024
|
Q4 FY2024
As of Sep 30, 2024
|
Q3 FY2024
As of Jun 30, 2024
|
Q2 FY2024
As of Mar 31, 2024
|
Q1 FY2024
As of Dec 31, 2023
|
Q4 FY2023
As of Sep 30, 2023
|
Q3 FY2023
As of Jun 30, 2023
|
Q2 FY2023
As of Mar 31, 2023
|
Q1 FY2023
As of Dec 31, 2022
|
Q4 FY2022
As of Sep 30, 2022
|
Q3 FY2022
As of Jun 30, 2022
|
Q2 FY2022
As of Mar 31, 2022
|
Q1 FY2022
As of Dec 31, 2021
|
Q4 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Accounts receivable (less allowances for doubtful accounts of $54, $42 and $73, respectively) | ||||||||||||||||||||
| Accrued utility revenues | ||||||||||||||||||||
| Income taxes receivable | ||||||||||||||||||||
| Inventories | ||||||||||||||||||||
| Derivative instruments | ||||||||||||||||||||
| Prepaid expenses | ||||||||||||||||||||
| Other current assets | ||||||||||||||||||||
| Held for sale assets | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Non-utility | ||||||||||||||||||||
| Utility | ||||||||||||||||||||
| Total property, plant and equipment | ||||||||||||||||||||
| Accumulated depreciation | ||||||||||||||||||||
| Property, plant and equipment, net (less accumulated depreciation of $5,253, $5,270 and $5,220, respectively) | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Utility regulatory assets | ||||||||||||||||||||
| Derivative instruments | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND EQUITY | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Current maturities of long-term debt | ||||||||||||||||||||
| Short-term borrowings | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Employee compensation and benefits accrued | ||||||||||||||||||||
| Deposits and advances | ||||||||||||||||||||
| Derivative instruments | ||||||||||||||||||||
| Held for sale liabilities | ||||||||||||||||||||
| Other current liabilities | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term debt | ||||||||||||||||||||
| Deferred income taxes | ||||||||||||||||||||
| Derivative instruments | ||||||||||||||||||||
| Other noncurrent liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Equity: | ||||||||||||||||||||
| UGI Corporation stockholders’ equity: | ||||||||||||||||||||
| Preferred Stock, without par value (authorized – 5,000,000 shares; issued – 0 and 0 Series A shares, respectively) | ||||||||||||||||||||
| UGI Common Stock, without par value (authorized — 450,000,000 shares; issued — 217,706,132, 217,033,282 and 216,929,085 shares, respectively) | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive income (loss) | ||||||||||||||||||||
| Treasury stock, at cost | ||||||||||||||||||||
| Total UGI Corporation stockholders’ equity | ||||||||||||||||||||
| Noncontrolling interests | ||||||||||||||||||||
| Total equity | ||||||||||||||||||||
| Total liabilities and equity |
Loading...
